Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria
Clinical trial NCT03503058 · COMPLETED
Trial details
- NCT number
- NCT03503058
- Sponsor
- Sanaria Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-07
- Primary completion
- 2024-02-27
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.